China Osteoporosis Market Analysis and Forecast, 2007 - 2015

Published Date >> January 2012
No. Of Pages >> 28
 

Single User License

$1500

      
Multi User License
$2500


Description


The Chinese Osteoporosis drug market is expected to grow at a CAGR of 14.4% from 2007 to 2015.

Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug market. The other key growth drivers for Chinese Osteoporosis market include increasing elderly aged population, rising living standards of the Chinese people and increasing awareness and bone health education.

 
Geographical analysis of Chinese Osteoporosis drug market shows that there is a huge growth potential for Osteoporosis drug in many cities including Shanghai, Beijing, Guangzhou, and Hangzhou.
 
Bisphosphonate is the leading Osteoporosis drug class in China for Osteoporosis treatment and is expected to remain so for next few years.
 
To gain a competitive advantage, market players should develop cost-competitive drugs with easy dosage pattern, which promote bone building effectively.
 
Large numbers of patients are unable to comply with the strict dosage schedule of traditional Osteoporosis drugs. Further research and development can address the unmet need by coming up with drugs that have a convenient dosage schedule with better efficacy and safety compared to traditional treatment of Osteoporosis.
 
After 2012, the Parathyroid Hormone and SERM Osteoporosis drug class market is expected to decline because of anticipated growth of Prolia (Denosumab), which will eat away other drugs’ market share.

Table of Content

1. Executive Summary

2. China Osteoporosis Market

2.1. Market Overview
2.2. Growth Drivers and Opportunities
2.3. Recent Market Developments
2.4. Competitive Strategies
2.5. Future Outlook
2.6. Driving Factor Analysis of China Osteoporosis Market
2.6.1. Demand Side Drivers
2.6.2. Supply Side Drivers
2.6.3. Restraints
2.6.4. Opportunities
2.6.5. Key Competitive Points

3. China Osteoporosis Market Share (2007 - 2015)

3.1. By Drug Class - Osteoporosis Market Share & Forecast
3.2. By Drug Market Share - Osteoporosis Market Share & Forecast

4. Osteoporosis Drugs Classes Market & Forecast (2007 - 2015)
4.1. China Bisphosphonate Market & Forecast
4.2. China Selective Estrogen Receptor Modulators (SERM) Market & Forecast
4.3. China Parathyroid Hormone (PTH) Market & Forecast
4.4. China Calcitonin Market & Forecast

5. Osteoporosis Drugs Market Analysis & Forecast (2007 - 2015)
5.1. Bisphosphonate Drugs Market Analysis
5.1.1. Fosamax (Alendronate)
5.1.2. Bonviva/Boniva (Ibandronic Acid)
5.1.3. Reclast/Aclasta
5.1.4. Actonel (Risedronate)
5.2. SERMs Drugs Market Analysis
5.2.1. Evista (Raloxifene)
5.2.2. Viviant/ Conbriza (Bazedoxifene)
5.3. Parathyroid Hormone Drugs Market Analysis
5.3.1. Forteo
5.4. Calcitonin Drugs Market Analysis
5.4.1. Miacalcin
5.5. Prolia (Denosumab)

6. Pipeline Drugs in Osteoporosis Market Analysis
6.1. Odanacatib (MK 0822)
6.2. Aprela (Bazedoxifene)

7. Recommendations
7.1. Market Strategy for Success
7.2. Barriers to be Considered
7.3. Future Assumption

List of Table:

NA

List of Charts:

NA

More Reports in Pharmaceutical

EGIS Pharmaceuticals Plc: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Blue Cross Blue Shield of Michigan: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Nissan Chemical Industries, Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Eisai Co., Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Asahi Kasei Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Align Technology, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report





By This Publisher

Crop Protection Chemicals Market - Global And Developing Countries (China, India And Brazil) Analysis, Market Size, Trends And Forecasts (2009 - 2016)


Pesticides Market : India, China And Japan Industry Analysis, Size, Share & Forecast (2009 - 2016)


Polyurethanes (Pu) Market: Global Industry Analysis, Size, Share & Forecast (2009 - 2016)


Computed Tomography (CT) Market: Global Industry Analysis, Size, Share & Forecast (2010 - 2017)


Nutraceutical Ingredients Market - Global Industry Analysis, Market Size, Share, Growth And Forecast 2007 - 2017


Organic Electronics Market - Global Industry Analysis, Market Size, Share, Growth And Forecast 2012 - 2018


Baby Care Products Market - Global Industry Analysis, Market Size, Share, Growth And Forecast 2007 - 2017


U.S. Lighting Products Market Analysis And Forecast By Retailers 2011 - 2016


Ultrasound Market: Global Market Analysis, Size, Share & Forecast (2012 - 2017)


X-Ray Market: Global Market Analysis, Size And Forecast (2012 - 2017)




Other Details :

Publisher : Transparency Market Research

Report Category : Pharmaceutical

Formats of Delivery :  E-mail Delivery (PDF)



Similar Industry Reports :

China Osteoporosis Market Analysis and Forecast, 2007 - 2015